HCW Biologics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 200.00 shares, a 40.65% decline from fiscal 2024.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 337.00 shares, a 99.77% decline from fiscal 2023.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 148.66K shares, a 37.43% increase from fiscal 2022.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 108.18K shares, a 47.60% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 200.00 shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 337.00 shares 10-K · filed 2026-03-31 | |
| 2023-12-31 | 148.66K shares 10-K · filed 2025-03-28 | |
| 2022-12-31 | 108.18K shares 10-K/A · filed 2024-05-15 | |
| 2021-12-31 | 206.46K shares 10-K · filed 2023-03-28 | |
| 2020-12-31 | 75.85K shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |